BICO Group AB (publ) (BICO.ST)
SEK 35.86
(-5.13%)
SEK 35.86
(-5.13%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 927.9 Million SEK | -17.56% |
| 2021 | 1.12 Billion SEK | 250.83% |
| 2020 | -746.19 Million SEK | -1801.38% |
| 2019 | -39.24 Million SEK | -74.9% |
| 2018 | -22.43 Million SEK | -217.73% |
| 2017 | -7.06 Million SEK | -12510.71% |
| 2016 | -56 Thousand SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | 1.31 Billion SEK | 8.36% |
| 2023 Q1 | 1.01 Billion SEK | 9.38% |
| 2023 Q2 | 1.21 Billion SEK | 19.63% |
| 2022 Q1 | 1.27 Billion SEK | 13.3% |
| 2022 Q4 | 927.9 Million SEK | -32.63% |
| 2022 Q3 | 1.37 Billion SEK | 6.41% |
| 2022 Q2 | 1.29 Billion SEK | 1.5% |
| 2022 FY | 927.9 Million SEK | -17.56% |
| 2021 Q4 | 1.12 Billion SEK | -8.61% |
| 2021 Q1 | -1.06 Billion SEK | 0.0% |
| 2021 FY | 1.12 Billion SEK | 250.83% |
| 2021 Q2 | 1.08 Billion SEK | 201.93% |
| 2021 Q3 | 1.23 Billion SEK | 13.05% |
| 2020 FY | -746.19 Million SEK | -1801.38% |
| 2020 Q3 | -746.19 Million SEK | -902.25% |
| 2020 Q1 | -60.58 Million SEK | -278.93% |
| 2020 Q2 | -74.45 Million SEK | -22.89% |
| 2019 Q2 | -7.97 Million SEK | 30.65% |
| 2019 Q1 | -11.5 Million SEK | 46.8% |
| 2019 Q3 | -39.24 Million SEK | -391.92% |
| 2019 FY | -39.24 Million SEK | -74.9% |
| 2019 Q4 | -15.98 Million SEK | 59.26% |
| 2018 Q2 | -12.41 Million SEK | 78.37% |
| 2018 FY | -22.43 Million SEK | -217.73% |
| 2018 Q4 | -21.62 Million SEK | 3.62% |
| 2018 Q3 | -22.43 Million SEK | -80.69% |
| 2018 Q1 | -57.41 Million SEK | -271.14% |
| 2017 Q2 | -18.43 Million SEK | 26.91% |
| 2017 Q4 | -15.46 Million SEK | -119.05% |
| 2017 FY | -7.06 Million SEK | -12510.71% |
| 2017 Q1 | -25.22 Million SEK | 12.15% |
| 2017 Q3 | -7.06 Million SEK | 61.69% |
| 2016 FY | -56 Thousand SEK | 0.0% |
| 2016 Q4 | -28.71 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | 2739.904% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 24.37% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 24.37% |
| Arcoma AB | -1.12 Million SEK | 82360.638% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | -744.451% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | -620.419% |
| CellaVision AB (publ) | -56.94 Million SEK | 1729.553% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | 6337.145% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | 11074.299% |
| C-Rad AB (publ) | -127.6 Million SEK | 827.194% |
| Duearity AB (publ) | 10.23 Million SEK | -8969.495% |
| Dignitana AB (publ) | 13.07 Million SEK | -6995.664% |
| Episurf Medical AB (publ) | -52.7 Million SEK | 1860.721% |
| Getinge AB (publ) | 5.4 Billion SEK | 82.842% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | 2747.128% |
| Iconovo AB (publ) | -10.75 Million SEK | 8727.346% |
| Integrum AB (publ) | -10.47 Million SEK | 8956.935% |
| Luxbright AB (publ) | -13.83 Million SEK | 6807.647% |
| Mentice AB (publ) | -49.56 Million SEK | 1972.125% |
| OssDsign AB (publ) | -162.78 Million SEK | 670.005% |
| Paxman AB (publ) | -11.41 Million SEK | 8231.627% |
| Promimic AB (publ) | -50.32 Million SEK | 1943.888% |
| Qlife Holding AB (publ) | 19.07 Million SEK | -4765.758% |
| SciBase Holding AB (publ) | -27.32 Million SEK | 3495.916% |
| ScandiDos AB (publ) | -1.53 Million SEK | 60707.446% |
| Sectra AB (publ) | -772.85 Million SEK | 220.062% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 508.994% |
| Senzime AB (publ) | -139.54 Million SEK | 764.966% |
| SpectraCure AB (publ) | -50.23 Million SEK | 1947.155% |
| Stille AB | -178.5 Million SEK | 619.82% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 24.438% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 532.283% |